Molecular structure of 3,4-Dihydroxybenzylamine hydrobromide, CAS Number: 16290-26-9
3,4-Dihydroxybenzylamine hydrobromide (CAS 16290-26-9)
Alternate Names:
DHBA hydrobromide
CAS Number:
16290-26-9
Molecular Weight:
220.06
Molecular Formula:
C7H9NO2•Hbr
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
3,4-Dihydroxybenzylamine hydrobromide finds versatile applications in scientific research. It has been employed in synthesizing various compounds like 3,4-dihydroxybenzaldehyde, 3,4-dihydroxybenzyl alcohol, and 3,4-dihydroxybenzylamine. Moreover, this compound has been utilized in the production of fluorescent dyes, for biological molecule imaging and detection. As an acid-base catalyst, 3,4-Dihydroxybenzylamine hydrobromide facilitates reactions with other compounds. It also serves as an electron-donating group.
3,4-Dihydroxybenzylamine hydrobromide (CAS 16290-26-9) References
- High-performance liquid chromatography with electrochemical detection applied to the analysis of 3,4-dihydroxymethamphetamine in human plasma and urine. | Segura, M., et al. 2002. J Chromatogr B Analyt Technol Biomed Life Sci. 769: 313-21. PMID: 11996497
- Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan. | Prezioso, JA., et al. 1992. J Invest Dermatol. 99: 289-93. PMID: 1512464
- Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells. | Prezioso, JA., et al. 1990. Pigment Cell Res. 3: 49-54. PMID: 2117268
- Tumor inhibition and hematological improvements by dopamine analog 3,4-dihydroxybenzylamine in mice bearing transplantable carcinoma. | Lahiri, T., et al. 1990. Neoplasma. 37: 387-93. PMID: 2234200
- Determination of L-3,4-dihydroxyphenylalanine in blood by high-performance liquid chromatography after solvent extraction. | Tsuchiya, H. and Hayashi, T. 1989. J Chromatogr. 491: 291-8. PMID: 2808616
- Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells. | Kable, EP. and Parsons, PG. 1989. Cancer Chemother Pharmacol. 23: 1-7. PMID: 2909284
- Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma. | FitzGerald, GB. and Wick, MM. 1987. J Invest Dermatol. 88: 66-70. PMID: 2947954
- Antitumor effects of biologic reducing agents related to 3,4-dihydroxybenzylamine: dihydroxybenzaldehyde, dihydroxybenzaldoxime, and dihydroxybenzonitrile. | Wick, MM. and FitzGerald, GB. 1987. J Pharm Sci. 76: 513-5. PMID: 3312571
- Oxidative Polymerization of 3,4-Dihydroxybenzylamine─The Lower Homolog of Dopamine. | Petran, A., et al. 2023. Langmuir. 39: 5610-5620. PMID: 37022985
- Potentiation by alpha-difluoromethylornithine of the activity of 3,4-dihydroxybenzylamine, a tyrosinase-dependent melanolytic agent, against B16 melanoma. | Prakash, NJ., et al. 1985. Biochem Pharmacol. 34: 1887-90. PMID: 3924051
- 3,4-Dihydroxybenzylamine: an improved dopamine analog cytotoxic for melanoma cells in part through oxidation products inhibitory to dna polymerase. | FitzGerald, GB. and Wick, MM. 1983. J Invest Dermatol. 80: 119-23. PMID: 6401786
- Striatal transporter for dopamine: catechol structure-activity studies and susceptibility to chemical modification. | Meiergerd, SM. and Schenk, JO. 1994. J Neurochem. 62: 998-1008. PMID: 8113819
- Breakdown of 3,4-dihydroxybenzylamine and dopamine in plasma of various animal species by semicarbazide-sensitive amine oxidase. | Boomsma, F., et al. 1993. J Chromatogr. 621: 82-8. PMID: 8308091
- Oxidation of 3,4-dihydroxybenzylamine affords 3,4-dihydroxybenzaldehyde via the quinone methide intermediate. | Sugumaran, M. 1995. Pigment Cell Res. 8: 250-4. PMID: 8789199
- Determination of catecholamines in sheep plasma by high-performance liquid chromatography with electrochemical detection: comparison of deoxyepinephrine and 3,4-dihydroxybenzylamine as internal standard. | He, H., et al. 1997. J Chromatogr B Biomed Sci Appl. 701: 115-9. PMID: 9389345
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3,4-Dihydroxybenzylamine hydrobromide, 250 mg | sc-232009 | 250 mg | $34.00 | |||
3,4-Dihydroxybenzylamine hydrobromide, 1 g | sc-232009A | 1 g | $75.00 |